Post Profile






Imaging with New Biomarker Tracks Tumor Progression, Response to Treatment for Common Brain Cancer

UT Southwestern Medical Center researchers have developed an MRI-based method that can track the state and progression of a common type of genetically mutated brain cancer.
read more

share

Related Posts


A.M. Vitals: Gene Mutation Yields Insight into Common Brain Cancer

Health : Wall Street Journal Health Blog

Here's what's making health news this morning: Some Brain Tumors Are Linked to a Gene Defect (WSJ): Researchers found a genetic mutation connected to a common and aggressive form of brain center. In Quest to Explain Shootings, Probi...

Brain Tumors And Other Cancers Identified By Immortality Gene Mutation; Finding Provides New Targets For Drug Development

Health : Medical News Today

Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by ...

Imaging Technology For Looking Inside Brain May Help Test New Brain Cancer Drugs

Health : Medical News Today

Using imaging technology that reveals whether brain tumors have a particular genetic mutation known as IDH, a team of academic and pharmaceutical company researchers has developed a way to help doctors select the right treatment, an...

Tumor-Suppressing Gene Works by Restraining Mobile Genetic Elements That Can Lead to Genomic Instability, UT Southwestern Study Finds

Health : Newswise Medical News

The most commonly mutated gene in cancer, p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.

UT Southwestern Cancer Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation Involved in Lung, Colon, and Pancreatic Cancers

Health : Newswise Medical News

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

Comments


Copyright © 2016 Regator, LLC